Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. Amazon Location Service.

Clinical trial site

Cincinnati Children's Hospital Medical Center

Cincinnati Children's Hospital Medical Center in Cincinnati, Ohio, United States is listed as a site for 1,531 registered clinical trials, 453 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,531
Ongoing 453

This page covers the site record Cincinnati Children's Hospital Medical Center in Cincinnati, Ohio, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the Cincinnati Children's Hospital Medical Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,531 trials counted.

  • Phase 1 188 trials
  • Phase 1/2 107 trials
  • Phase 2 294 trials
  • Phase 2/3 30 trials
  • Phase 3 281 trials
  • Phase 4 47 trials
  • Not applicable 269 trials
  • Observational 309 trials
  • Expanded access 6 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 454 trials
  • Completed 896 trials
  • Terminated 151 trials
  • Other 30 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 105

1992: 1 trials (Phase 3 1) 1993: 1 trials (Not applicable 1) 1994: 1 trials (Observational 1) 1996: 2 trials (Observational 1, Phase 2 1) 1997: 3 trials (Phase 3 3) 1998: 4 trials (Observational 1, Phase 3 1, Phase 2 1, Phase 1 1) 1999: 4 trials (Observational 1, Phase 3 2, Phase 2 1) 2000: 6 trials (Observational 1, Phase 3 2, Phase 2 1, Phase 1 2) 2001: 12 trials (Observational 2, Not applicable 1, Phase 3 4, Phase 2 1, Phase 1/2 1, Phase 1 3) 2002: 12 trials (Observational 1, Not applicable 2, Phase 4 1, Phase 3 3, Phase 2 3, Phase 1 2) 2003: 15 trials (Observational 2, Not applicable 2, Phase 3 4, Phase 2/3 1, Phase 2 3, Phase 1/2 1, Phase 1 2) 2004: 30 trials (Observational 6, Not applicable 4, Phase 3 8, Phase 2/3 1, Phase 2 5, Phase 1 6) 2005: 38 trials (Observational 8, Not applicable 4, Phase 3 6, Phase 2 11, Phase 1/2 3, Phase 1 6) 2006: 34 trials (Observational 8, Not applicable 3, Phase 3 8, Phase 2 5, Phase 1/2 7, Phase 1 3) 2007: 43 trials (Observational 5, Not applicable 5, Phase 4 1, Phase 3 18, Phase 2 4, Phase 1/2 6, Phase 1 4) 2008: 40 trials (Observational 8, Not applicable 4, Phase 4 1, Phase 3 12, Phase 2/3 1, Phase 2 8, Phase 1/2 3, Phase 1 3) 2009: 45 trials (Observational 5, Not applicable 7, Phase 4 1, Phase 3 9, Phase 2/3 1, Phase 2 13, Phase 1/2 1, Phase 1 8) 2010: 56 trials (Observational 10, Not applicable 10, Phase 4 3, Phase 3 7, Phase 2/3 1, Phase 2 9, Phase 1/2 8, Phase 1 8) 2011: 45 trials (Observational 11, Not applicable 10, Phase 4 1, Phase 3 4, Phase 2/3 1, Phase 2 6, Phase 1/2 2, Phase 1 10) 2012: 64 trials (Observational 14, Not applicable 18, Phase 4 1, Phase 3 6, Phase 2/3 1, Phase 2 14, Phase 1/2 4, Phase 1 6) 2013: 70 trials (Observational 13, Not applicable 14, Phase 4 2, Phase 3 8, Phase 2/3 2, Phase 2 12, Phase 1/2 4, Phase 1 15) 2014: 67 trials (Observational 16, Not applicable 11, Phase 3 6, Phase 2/3 1, Phase 2 14, Phase 1/2 9, Phase 1 10) 2015: 74 trials (Observational 17, Not applicable 13, Phase 4 4, Phase 3 13, Phase 2 15, Phase 1/2 4, Phase 1 8) 2016: 77 trials (Observational 17, Not applicable 15, Phase 4 4, Phase 3 13, Phase 2/3 4, Phase 2 15, Phase 1/2 2, Phase 1 7) 2017: 94 trials (Observational 17, Not applicable 13, Phase 4 1, Phase 3 21, Phase 2/3 1, Phase 2 26, Phase 1/2 5, Phase 1 10) 2018: 105 trials (Observational 22, Not applicable 15, Phase 4 3, Phase 3 20, Phase 2/3 3, Phase 2 22, Phase 1/2 7, Phase 1 13) 2019: 72 trials (Observational 13, Not applicable 9, Phase 4 2, Phase 3 16, Phase 2/3 1, Phase 2 15, Phase 1/2 6, Phase 1 10) 2020: 80 trials (Observational 24, Not applicable 15, Phase 4 4, Phase 3 15, Phase 2/3 1, Phase 2 14, Phase 1/2 4, Phase 1 3) 2021: 98 trials (Observational 21, Not applicable 15, Phase 4 3, Phase 3 21, Phase 2 21, Phase 1/2 7, Phase 1 10) 2022: 84 trials (Observational 18, Not applicable 17, Phase 4 2, Phase 3 17, Phase 2/3 5, Phase 2 7, Phase 1/2 9, Phase 1 9) 2023: 76 trials (Observational 15, Not applicable 17, Phase 4 7, Phase 3 10, Phase 2/3 2, Phase 2 13, Phase 1/2 6, Phase 1 6) 2024: 62 trials (Observational 9, Not applicable 20, Phase 4 2, Phase 3 6, Phase 2 15, Phase 1/2 5, Phase 1 5) 2025: 60 trials (Observational 11, Not applicable 13, Phase 4 2, Phase 3 11, Phase 2/3 2, Phase 2 11, Phase 1/2 2, Phase 1 8)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 45
2025 60
2024 62
2023 76
2022 84
2021 98
2020 80
2019 72
2018 105
2017 94

2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Conditions studied

The specific conditions of the trials that list this site, most trials first.